# A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer

> **NCT00371566** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 107 (actual)

## Conditions studied

- Squamous Cell Carcinoma of Head and Neck

## Interventions

- **DRUG:** Lapatinib oral tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00371566
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2010-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00371566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00371566, "A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00371566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*